Now official: CandorVision® Survey Results are Out!

Montreal, June 18, 2026 – CandorVision® (a division of CandorPharm® Inc.), a Canadian-owned and Canadian-operated company, is proud to announce that it is now official: HYLO® is Canada’s preferred lubricating eye drop brand among Canadian ophthalmologists.

Dry eye disease affects millions of Canadians and is a complex, multifactorial disorder of the tear film that may damage the ocular surface. It is commonly triggered by air conditioning, computer work, hormone changes, allergies, medications, environmental factors, eye surgery, and eye injuries. As dry eye prevalence continues to rise, health professionals and patients are seeking treatments they can rely on for consistent performance, comfort, and long‑lasting relief.

Over the years, CandorVision® has received excellent feedback from ophthalmologists, optometrists, health professionals, and patients regarding their positive experiences with HYLO®. Building on this, CandorVision® sought to gain deeper insights into how we can continue to support health professionals and their patients in the successful management of dry eye symptoms.

Last year, more than 100 Canadian ophthalmologists participated in an anonymous survey administered by AdHoc Research, a leading Canadian market research firm. The survey was designed to understand ophthalmologists’ perceptions of HYLO® treatments and the clinical scenarios in which they recommend lubricating dry eye drops. The research examined critical factors such as ingredient knowledge, pricing, clinical usage patterns, brand awareness, and overall perception among eye care specialists.

Main takeaways from the survey:

• HYLO® is the most frequently recommended (>80%) lubricating eye drop brand among Canadian ophthalmologists surveyed.

• Two-thirds of surveyed ophthalmologists trust and personally use HYLO® for themselves and/or their family members, and over 90% have used HYLO® in the past year.

https://youtu.be/JLQfwOhBxMM

“When ophthalmologists choose a treatment for their patients and for their families, it reflects a high level of trust built through clinical experience. These insights highlight HYLO®’s continued role in effective dry eye management.” says Dr. Frank Heidemann, President & CEO of CandorVision®. “The feedback confirms that patients are benefiting from HYLO®’s unique, preservative-free, high molecular weight sodium hyaluronate, “Made in Germany” formulation.”

CandorVision® remains committed to delivering Gold Standard dry eye and lid hygiene treatments, which both eye health professionals and their patients alike can trust and confidently recommend.

HYLO® is available Canada-wide at pharmacies behind the counter alongside the entire HYLO® family of dry eye & allergy treatments, OCUNOX® eye ointment, CALMO® EYE SPRAY, and CALMO® / NACLINO® lid hygiene, and at selected optometry and ophthalmology clinics.

ABOUT CANDORVISION®

CandorVision® (a division of CandorPharm® Inc.) is a Canadian-owned and operated company that develops and markets the highest quality ophthalmic medical devices for dry eye and lid hygiene treatment for the Canadian market. CandorVision® provides cutting-edge technology to health professionals, developed with the protection of our environment and environmentally compliant techniques in mind.

Source:

Based on a 2025 survey of Canadian ophthalmologists, administered by AdHoc Research. Data on file.